For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Fear and speculation as DHBs draw up radical new pharmacy contract
+Print Archive
NEWS
Fear and speculation as DHBs draw up radical new pharmacy contract
Wednesday 11 April 2018, 06:00 AM

Pharmacists are suspicious of DHB motives in moving from their current Community Pharmacy Services Agreement (CPSA) to a new Integrated Pharmacist Services in the Community Agreement(IPSCA) contract. Image courtesy of Pharmacy Today
Pharmacists up and down the country have been attending roadshows explaining the pros and cons of a new community pharmacy contract. Ruth Brown explains what’s up
A shake-up of the pharmacy sector looks to be on the cards as DHBs redraw the proposed community pharmacy contract with major changes, including spl, CPSA
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.